XML 60 R49.htm IDEA: XBRL DOCUMENT v3.25.2
Business Concentrations (Details)
$ in Thousands
Jun. 30, 2025
USD ($)
Theramex [Member]  
Business Concentrations [Line Items]  
License revenue percentage 100.00%
Mayne Pharma [Member]  
Business Concentrations [Line Items]  
Royalty receivable short term portion $ 3,743
Royalty receivable long term portion $ 14,840